Abbvie Inc (NYSE:ABBV)
| 107.91 Delayed Data As of Apr 16 |  +1.02 / +0.95%Today’s Change | 79.11 Today|||52-Week Range 113.41 | +0.71% Year-to-Date |
ABBV Regular Dividend: ABBV began trading ex-dividend on 04/14/21. A $1.30 dividend will be paid to shareholders of record as of 04/15/21.
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 106.89 |
| Today’s open | 105.99 |
| Day’s range | 105.63 - 108.54 |
| Volume | 8,207,672 |
| Average volume (3 months) | 7,267,309 |
| Market cap | $190.4B |
Data as of 4:00pm ET, 04/16/2021
Growth & Valuation
| Earnings growth (last year) | -48.39% |
| Earnings growth (this year) | +17.43% |
| Earnings growth (next 5 years) | +4.45% |
| Revenue growth (last year) | +37.69% |
| P/E ratio | 39.7 |
| Price/Sales | 3.91 |
| Price/Book | 14.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.80 | +1.04% |
| NVSNovartis | +0.81 | +0.93% |
| LLYEli Lilly and Co | +3.35 | +1.80% |
| PFEPfizer | +0.97 | +2.58% |
Data as of 7:32pm ET, 04/16/2021
Financials
| Next reporting date | April 30, 2021 |
| EPS forecast (this quarter) | $2.81 |
| Annual revenue (last year) | $45.8B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 9.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
